Corrigendum to “Targeting ERK1/2 protein-serine/threonine kinases in human cancers” [Pharmcol. Res. 142 (2019) 151–168]

Publication date: Available online 3 April 2019Source: Pharmacological ResearchAuthor(s): Robert Roskoski

Source: Pharmacological Research - April 3, 2019 Category: Drugs & Pharmacology Source Type: research